| Hazard ratio (95%CI) | P |
---|---|---|
OS | Â | Â |
AFP(ng/ml) (≤ 20 vs. >20) | 1.320 (0.666-2.615) | 0.426 |
γ-GT(U/I) (≤ 54 vs. >54) | 2.098 (1.073-4.103) | 0.030 |
Tumor differentiation (I+II vs. III+IV) | 1.228 (0.661-2.279) | 0.516 |
Tumor size (cm) | 1.102 (1.016-1.196) | 0.020 |
Vascular invasion (no vs. yes) | 4.351 (1.992-9.500) | 0.001 |
Capsule (complete vs. no) | 0.676 (0.332-1.375) | 0.280 |
HIF-1α mRNA (low vs. high) | 2.167 (1.185-3.965) | 0.012 |
COX-2 mRNA (low vs. high) | 2.557 (1.355-4.824) | 0.004 |
MMP7 mRNA (low vs. high) | 2.287 (1.217-4.301) | 0.010 |
PDGFRA mRNA (low vs. high) | 2.320 (1.225-4.394) | 0.010 |
HIF-1α protein (low vs. high) | 2.108 (1.120-3.969) | 0.021 |
DFS | Â | Â |
Age (year) | 0.990 (0.963-1.018) | 0.475 |
AFP(ng/ml) (≤ 20 vs. >20) | 1.707 (0.903-3.227) | 0.100 |
Tumor size (cm) | 1.090 (0.997-1.191) | 0.060 |
Tumor number (single vs. multiple) | 3.324 (1.818-6.079) | 0.001 |
Vascular invasion (no vs. yes) | 2.453 (1.192-5.047) | 0.015 |
Encapsulation (complete vs. no) | 1.573 (0.781-3.168) | 0.204 |
HIF-1α mRNA (low vs. high) | 2.359 (1.325-4.201) | 0.004 |
COX-2 mRNA (low vs. high) | 2.170 (1.201-3.921) | 0.010 |
MMP7 mRNA (low vs. high) | 1.499 (0.830-2.707) | 0.179 |
VEGF mRNA (low vs. high) | 1.702 (0.936-3.094) | 0.081 |
PDGFRA mRNA (low vs. high) | 1.910 (1.038-3.514) | 0.038 |
HIF-1α protein (low vs. high) | 2.265 (1.251-4.009) | 0.007 |